drugset / Trial / NCT02479022
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy Subjects
RandomizedSingle-groupDouble-blindTreatment
Summary
This trial is conducted in Europe. The aim of the trial is to investigate the safety, tolerability, pharmacokinetics (the exposure of the trial drug in the body) and pharmacodynamics (the effect of the investigated drug on the body) of insulin 320 in healthy subjects.
Timeline
- Start
- 2015-06
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin 320 | Unknown | 300 unknown | Oral |
| Subject | Insulin 320 | Unknown | 21600 unknown | Oral |
| Subject | insulin glargine | Protein / enzyme biologic | — | Subcutaneous |